Silver Export Award presented to AOP Orphan
9. 4. 2021AOP Orphan reports full validity of arbitral award against PharmaEssentia
25. 3. 2021Health Europe: AOP Orphan a European pioneer in the field of rare and complex diseases
18. 3. 2021AOP Orphan team covers all essential aspects of product development, starting with preclinical research & toxicology, extending to pharmaceutical & clinical development, including regulatory affairs, quality management & pharmacovigilance.
Partnering is of key importance for AOP Orphan. It allows further developing AOP Orphan’s rare disease portfolio and enables to approach patients beyond company’s core markets in Europe.